Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Tian Zhang
Nov 1, 2023, 18:54 |
Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 30, 2023, 13:42 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023
Starting from August 26, which is Women’s Equality Day in the United States—celebrating the 1920…
Oct 21, 2023, 21:40 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 9
We continue OncoDaily’s ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social…
May 24, 2023, 15:44 |
Positive
The results for the 2023 40 Under 40 in Cancer were announced!
Congratulations to all of the nominees and awardees! The members of the 2023 40 Under…
Oct 20, 2024, 18:08 |
Blog
SOX with or without perioperative camrelizumab in locally advanced gastric cancer
Erman Akkus shared on X: “Locally advanced gastric cancer. Perioperative camrelizumab plus low-dose rivoceranib and…
Oct 9, 2024, 10:36 |
Blog
Aalaa Mahmoud: The importance of addressing sexual health in breast cancer survivorship
Aalaa Mahmoud, Clinical Oncology Specialist at Egyptian Ministry of Health, posted the following on LinkedIn:…
Oct 4, 2024, 15:05 |
Insight
Iván R. González: Meta - analysis on the first-line treatment of NSCLC with EGFR mutation and brain metastases
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:…
Oct 4, 2024, 09:38 |
Insight
Myeloma Paper of the Day, October 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: In a cohort of 220 patients…
Sep 26, 2024, 14:19 |
Blog
Paolo Tarantino: ADC stability does not equal ADC tolerability
Paolo Tarantino shared a post by Raffaele Colombo, on X, adding: ''Antibody-drug conjugate (ADC) stability…
Sep 26, 2024, 09:30 |
Insight
Erman Akkus: Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’ cancer
Erman Akkus posted on X: “Neoadjuvant CRT vs. ChT for initially unresectable locally advanced ‘Colon’…
3
4
5
6
7
All:
68
Posts:
41 - 50
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Clinical Trials That Changed the Life of Cancer Patients: Insights from the CEO of EORTC, Dr. Denis Lacombe
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube